The CDC claims the reason why transgender women have disproportionately higher rates of HIV has nothing to do with sexual perversion and promiscuity, rather transgender people “face obstacles that make it harder to access HIV services – such as stigma and discrimination, inadequate employment or housing, and limited access to welcoming, supportive health care.”
“Addressing these barriers is essential to the health and well-being of transgender people and to meeting the goals of the proposed federal initiative Ending the HIV Epidemic: A Plan for America,” the CDC letter goes on to claim. “The Centers for Disease Control and Prevention is committed to working with you to make sure all transgender people can get the tools they need to prevent HIV and stay healthy if they have HIV.”
Mainstream media appears to be slack in reporting the increase of the horrific disease trends among the transgender population, offering the same silence that was observed when data emerged showing anal cancer to be increasing among homosexual men.
The CDC letter signed by Dr. Eugene McCray, M.D and Jonathan H. Mermin, M.D., M.P.H of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention clearly states that “Transgender women and men are at high risk for getting HIV.”
The same time the CDC published this information W.H.O announced that those who are transgender should not be classified as suffering from a mental illness in the 11the edition of their International Classification of Disease (ICD) publication. Readers will no longer find any reference to gender incongruence being a mental disorder due to the agency’s desire to “reduce the stigma associated with having gender dysphoria.”
“It was taken out from mental health disorders because we had better understanding that this wasn’t actually a mental health condition. Leaving it there was causing stigma, so in order to reduce the stigma, while also ensuring access to necessary health interventions this was placed to a different chapter, the sexual health chapter, in the new ICD.” stated Dr. Lale Say, a WHO employee who coordinates adolescents and at-risk populations.
“The decision was not only based on the advocacy or feedback from the concerned communities,” she continued. “All available evidence was reviewed and discussed by an external advisory group and together with the scientific basis of this condition and the feedback from the professional community and concerned communities formed the basis of this decision.This again was based on the scientific understanding that there was no clear evidence that this issue needs to be medicalized.”
